Profile
Fredrik Berg formerly worked at Procordia AB, as Legal Counsel, Pharmacia AB, as Head-Legal & Intellectual Property from 1997 to 2001, Biovitrum AB, as SVP-Legal & Intellectual Property in 2010, Kabi Pharmacia, as Legal Counsel, Kabivitrum AB, as Legal Counsel, and Swedish Orphan Biovitrum AB, as Vice President & General Counsel.
Mr. Berg received his graduate degree from the University of Stockholm.
Former positions of Fredrik Berg
| Companies | Position | End |
|---|---|---|
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | General Counsel | 2010-05-12 |
| Pharmacia AB | General Counsel | 2000-12-31 |
| Kabi Pharmacia | General Counsel | - |
| Procordia AB | General Counsel | - |
| Kabivitrum AB | General Counsel | - |
Training of Fredrik Berg
| University of Stockholm | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private companies | 5 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Pharmacia AB | Health Technology |
| Kabivitrum AB | |
| Procordia AB | Health Technology |
| Kabi Pharmacia |
- Stock Market
- Insiders
- Fredrik Berg
